We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Dollar General
DG
$25.9B
| $106M | 0.2% |
+474,621
| New | +$101M |
|
|
SGEN
102
DELISTED
Seagen Inc. Common Stock
SGEN
| $105M | 0.2% |
725,650
-671,853
| -48% | -$90.9M |
|
103
Insulet
PODD
$11.3B
| $104M | 0.2% |
390,272
-138,838
| -26% | -$34.1M |
|
104
Southwest Airlines
LUV
$22.1B
| $103M | 0.19% |
+2,239,647
| New | +$98.4M |
|
105
General Dynamics
GD
$105B
| $102M | 0.19% |
424,186
+150,592
| +55% | +$33.4M |
|
106
United Rentals
URI
$71.1B
| $99.6M | 0.19% |
280,393
+15,789
| +6% | +$5.16M |
|
107
Cboe Global Markets
CBOE
$29.8B
| $99.2M | 0.19% |
866,850
+299,212
| +53% | +$35.4M |
|
108
Paycom
PAYC
$6.78B
| $98.8M | 0.19% |
285,322
+186,812
| +190% | +$62.7M |
|
109
ZIM Integrated Shipping Services
ZIM
$3B
| $97.9M | 0.19% |
1,346,287
-1,361,749
| -50% | -$94.2M |
|
110
GSK
GSK
$103B
| $97.1M | 0.18% |
+1,782,800
| New | +$96.8M |
|
111
Icon
ICLR
$12.8B
| $96.4M | 0.18% |
396,331
-223,199
| -36% | -$55.9M |
|
112
Dave & Buster's
PLAY
$343M
| $95M | 0.18% |
1,934,404
+1,643,106
| +564% | +$65.7M |
|
|
SCHW
113
Charles Schwab
SCHW
$177B
| $94.4M | 0.18% |
1,120,104
+1,028,279
| +1,120% | +$90.5M |
|
114
Qiagen
QGEN
$8.53B
| $94.4M | 0.18% |
1,798,239
+960,398
| +115% | +$49.6M |
|
115
Macy's
M
$6.15B
| $94.2M | 0.18% |
3,865,435
+1,588,172
| +70% | +$40.7M |
|
116
International Flavors & Fragrances
IFF
$19.4B
| $94.1M | 0.18% |
716,717
-151,914
| -17% | -$20.2M |
|
117
Boot Barn
BOOT
$4.55B
| $93.9M | 0.18% |
990,454
+211,370
| +27% | +$20.1M |
|
118
McDonald's
MCD
$188B
| $93.4M | 0.18% |
377,681
+377,675
| +6,294,583% | +$94.1M |
|
|
ATVI
119
DELISTED
Activision Blizzard
ATVI
| $91.8M | 0.17% |
1,146,325
+943,154
| +464% | +$73.5M |
|
120
Revolve Group
RVLV
$1.79B
| $91.1M | 0.17% |
1,696,128
+365,290
| +27% | +$18.6M |
|
121
Copart
CPRT
$25.9B
| $90.7M | 0.17% |
2,891,128
+1,917,528
| +197% | +$60.9M |
|
122
Tenaris
TS
$29.1B
| $90.6M | 0.17% |
3,011,660
+1,135,745
| +61% | +$29.5M |
|
123
AT&T
T
$165B
| $90.3M | 0.17% |
5,057,177
-5,994,635
| -54% | -$111M |
|
|
MRO
124
DELISTED
Marathon Oil Corporation
MRO
| $88.9M | 0.17% |
+3,542,394
| New | +$76.1M |
|
|
SF
125
Stifel
SF
$12.3B
| $88.9M | 0.17% |
+1,964,862
| New | +$94.3M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.